SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS

参与西南肿瘤组（SWOG）是一个主要的 血液科临床研究工作的一部分- 俄克拉荷马州大学医学系肿瘤学 健康科学中心（OUHSC）。 这一努力的结果是， 进入SWOG的合格和可评价患者数量一致 审判 俄克拉荷马州大学的SWOG协议提供了主要的 俄克拉荷马州居民有机会参与大规模的， 设计的临床试验。 患者通过父母双方累积 机构和附属CGOP。 大多数患者，包括 大量的美洲原住民和俄克拉荷马州农村人， 这些医生是这个网络的一部分。 全年应计 网络已经有97名患者。 我们一直在努力增加我们在学术领域的参与， 临床试验方面。 在成员机构，我们专注于 我们在五个领域的努力，包括乳腺癌，头颈癌， 泌尿生殖系统癌症、肺癌和血液恶性肿瘤。 这 努力的结果是建立了多学科方案 在这些领域，这有助于促进识别和 根据SWOG方案招募患者。 此外，它还允许 制定可作为试点的内部协议 未来的SWOG试验。

Participation in the Southwest Oncology Group (SWOG) has been a major part of the clinical investigative effort of the section of Hematology- Oncology in the Department of Medicine at the University of Oklahoma Health Sciences Center (OUHSC). This effort results in the enrollment of a consistent number of eligible and evaluable patients into SWOG trials. SWOG protocols at the University of Oklahoma provide the major opportunity for Oklahoma residents to participate in large scale, well designed clinical trials. Patients are accrued via both the parent institution and affiliated CGOPs. Most patients in the state, including a large number of Native Americans and rural Oklahomans, are treated by physicians who are part of this network. Annual accrual for the entire network has been ninety-seven patients. We have been working to increase our involvement in the scholarly aspects of clinical trials. At the member institution, we have focused our efforts in five areas including breast cancer, head and neck cancer, genitourinary cancer, lung cancer, and hematological malignancies. This effort has resulted in the establishment of multidisciplinary programs in these areas which has helped to facilitate identification and enrollment of patients on SWOG protocols. In addition, it has allowed for the development of in-house protocols which might serve as pilot studies for future SWOG trials.